This seminar will provide practical advice on the borderline issues concerning drug/device combination products and provide key guidance on the regulatory strategy to follow.
Drug/Device and Device/Drug Combinations in the EU
Jan 17th, 2012Jan 18th, 2012
Latest in Home
Half of false-negative DBT exams are missed cancers
October 5, 2026
GE HealthCare to acquire Sofie Biosciences for $945M
October 5, 2026
Ultrasound MinnieCast, Episode 18: SDMS 2026
October 2, 2026














